Lunai Bioworks (LNAI) Amortizatization of Intangibles (2013 - 2022)
Lunai Bioworks (LNAI) posted quarterly Amortizatization of Intangibles of $70074.0 for Q1 2022, down 5.65% year-over-year from $74274.0 in Q1 2021, and up 1.03% quarter-over-quarter from $69357.0 in Q4 2021.
Lunai Bioworks (LNAI) Amortizatization of Intangibles (2013 - 2022) Analysis & Trends
Lunai Bioworks' Amortizatization of Intangibles history runs 6 years deep, the most recent figure standing at $70074.0 for Q1 2022.
- In Q1 2022, Amortizatization of Intangibles fell 5.65% year-over-year to $70074.0; the TTM figure through Mar 2022 stood at $276061.0 (down 54.89% YoY), while the FY2021 annual figure was $267881.0, up 3.96% from the prior year.
- Amortizatization of Intangibles for Q1 2022 stood at $70074.0, up from $69357.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $397685.0 in Q2 2020, with the low at $65981.0 in Q3 2020.
- The 3-year median for Amortizatization of Intangibles is $69715.5 (2021), against an average of $110997.4.
- Peak annual rise in Amortizatization of Intangibles reached 4.06% in 2021, while the deepest fall reached 82.91% in 2021.
- Lunai Bioworks' Amortizatization of Intangibles stood at $73978.0 in 2020, then declined by 6.25% to $69357.0 in 2021, then increased by 1.03% to $70074.0 in 2022.
- Business Quant data shows LNAI's Amortizatization of Intangibles at $70074.0 in Q1 2022, $69357.0 in Q4 2021, and $68657.0 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 678,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Lunai Bioworks | 6.87 Mn | 3.72 Mn | 20,942.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 70,074.00 |
| Mar 31, 2022 | 70,074.00 |
| Dec 31, 2021 | 69,357.00 |
| Dec 31, 2021 | 69,357.00 |
| Sep 30, 2021 | 68,657.00 |
| Sep 30, 2021 | 68,657.00 |
| Jun 30, 2021 | 67,973.00 |
| Jun 30, 2021 | 67,973.00 |
| Mar 31, 2021 | 74,274.00 |
| Mar 31, 2021 | 74,274.00 |
| Dec 31, 2020 | 73,978.00 |
| Dec 31, 2020 | 73,978.00 |
| Sep 30, 2020 | 65,981.00 |
| Sep 30, 2020 | 65,981.00 |
| Jun 30, 2020 | 397,685.00 |
| Jun 30, 2020 | 397,685.00 |
| Dec 31, 2017 | 6,700.00 |
| Dec 31, 2017 | 6,700.00 |
| Sep 30, 2017 | 5,297.00 |
| Sep 30, 2017 | 5,297.00 |